93 Results (Page 1 of 8)
Malaysia Markets Research Reports
Malaysia Diabetes Devices Market Analysis
The Malaysia Diabetes Devices Market is expected to witness growth from $37 Mn in 2022 to $65 Mn in 2030 with a CAGR of 7.40% for the forecasted year 2022-2030. Patients travel from all over the world to Malaysia for medical tourism, which is well-recognized for doing so. A key factor in the expansion of the diabetes device market is the availability of high-quality diabetes devices and services for patients seeking medical treatment in the country. The market is segmented by type and by the end user. Some key players in this market include GA2 Medical, Transmedia Healthcare, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Malaysia Cardiac Surgery Instruments Market Analysis
The Malaysia Cardiac Surgery Instruments Market is expected to witness growth from $3 Mn in 2022 to $6 Mn in 2030 with a CAGR of 6.80% for the forecasted year 2022-2030. Malaysia is a common place for medical tourism because it has so many top-notch medical facilities and professionals, this is predicted to raise demand for cutting-edge medical equipment and technology, such as that used in cardiac surgery. The market is segmented by type, application and by end user. Some key players in this market include GA2 Medical, Transmedia Healthcare, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Malaysia Artificial Intelligence (AI) in Healthcare Market Analysis
The Malaysia Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.01 Bn in 2022 to $0.22 Bn by 2030, registering a CAGR of 45.42% during the forecast period of 2022 - 2030. The market will be driven by the collaborative efforts from the government & private sectors and the introduction of structured regulations & guidelines for the use of AI in healthcare. The market is segmented by healthcare components & by healthcare applications. Some of the major players include Microsoft Healthcare, Naluri & Nova MSC Bhd.
Malaysia Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Malaysia Liver Disease Therapeutics market will reach a value of $59 Mn from $37 Mn in 2022, growing at a CAGR of 5.9% during 2022-2030. Liver Disease Therapeutics in Malaysia is dominated by a few domestic pharmaceutical companies such as Pharmaniaga, Kotra Pharma, and Hovid. The Liver Disease Therapeutics market in Malaysia is segmented into different types of disease and different therapy types. Some of the major factors affecting the Malaysia Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Malaysia Anti Aging Therapeutics Market Analysis
Malaysia anti-aging therapeutics market is projected to grow from $1 Mn in 2022 to $3 Mn in 2030 with a CAGR of 16.73% for the year 2022-2030. Being the top destination for medical tourism by providing anti-aging treatments at affordable cost, the Malaysia anti-aging therapeutics market is expected to witness growth during the forecast period. The Malaysia anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the major players in the market include Alpha Biologics, Progenix, and Quanta System.
Malaysia Biomaterials in Healthcare Market Analysis
The Malaysia Biomaterials in Healthcare Market is expected to witness growth from $251 Mn in 2022 to $687 Mn in 2030 with a CAGR of 13.40% for the forecasted year 2022-2030. Malaysia is seeing an increase in demand for cosmetic and plastic surgery due to growing disposable incomes and the availability of reasonably priced, high-quality healthcare services. Because biomaterials are frequently used in these procedures, manufacturers have chances to supply the market. The market is segmented by type and by application. Some key players in this market include: Bioalpha Holdings Berhad, Biocon Sdn Bhd, Hovid Berhad, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Malaysia 3D Printing Medical Devices Market Analysis
Malaysia 3D Printing Medical Device Market is expected to witness growth from $5 Mn in 2022 to $16 Mn in 2030 with a CAGR of 16.50% for the forecasted year 2022-2030. In Malaysia, the demand for Medical devices like implants, prosthetics, and orthotics—which can be created using 3D printing technology—is being driven by Malaysia's ageing population. The market segmented by application, by technology and by end user. Some key players in this market include: Vigilenz Medical Devices, GE Healthcare, Stryker, Teleflex Medical, Siemens Healthineers and Philips Healthcare.
Malaysia Healthcare Insurance Market Analysis
The Malaysia healthcare insurance market is projected to grow from $3.26 Bn in 2022 to $5.94 Bn by 2030, registering a CAGR of 7.8% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare costs, government initiatives, a rise in medical tourism and technological advancements. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include Tune Protect, Etiqa Insurance, Hong Leong Assurance, Great Eastern Life Assurance and Generali.
Malaysia ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Malaysia's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $48 Mn in 2022 to $86 Mn in 2030 with a CAGR of 7.7% for the year 2022-30. The rise in the prevalence of ADHD cases in Malaysia and the demand for novel treatment options are responsible for the growth of the market. The Malaysia ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Royce Pharma, GoodScience, and Eli Lilly are some of the key players in the market.
Malaysia Healthcare Claims Management Market Analysis
The Malaysia healthcare claims management market is projected to grow from $42.93 Mn in 2022 to $233.82 Mn by 2030, registering a CAGR of 23.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be technological advancements, increasing healthcare spending and government initiative. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include MediExpress, REMEDi, Genpact, Cognizant and Accenture.
Malaysia Home Healthcare Market Analysis
The Malaysia home healthcare market was valued at $583 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022 to 2030 and will reach $1074 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by component and product. Some key players in this market are Noble care, Genesis home healthcare, Sunway home healthcare, 24 Angles home care, Care giver Asia, Nurse at home, Cality Care
Malaysia Oncology Clinical Trials Market Analysis
Malaysia's oncology clinical trials market is projected to grow from $20.3 Mn in 2022 to $31.7 Mn by 2030, registering a CAGR of 5.7% during the forecast period of 2022-30. The market will be driven by the rise of oncology clinical trials in Malaysia, a well-established clinical research infrastructure, and government funding. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & Biocon Malaysia.
Malaysia Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Malaysia Liver Cancer Therapeutics market will reach a value of $17.5 Mn from $4.71 Mn in 2022, growing at a CAGR of 17.8% during 2022-2030. Liver Cancer Therapeutics in Malaysia is dominated by a few domestic pharmaceutical companies such as Pharmaniaga, Pantai Hospital and National Cancer Institute. The Liver Cancer Therapeutics market in Malaysia is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Malaysia Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Malaysia Oncology Drugs Market Analysis
By 2030, it is anticipated that the Malaysia oncology drugs market will reach a value of $xx Mn from $315.83 Mn in 2022, growing at a CAGR of xx% during 2022-30. The oncology drugs market in Malaysia is dominated by a few domestic pharmaceutical companies such as Pharmaniaga Berhad, Biocon Sdn Bhd, and Duopharma Biotech. The oncology market in Malaysia is segmented into different therapeutic areas and different treatment types. The major factors affecting the Malaysia oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of Malaysia.
Malaysia Patient Engagement Solutions Market Analysis
Malaysia's patient engagement solutions market is projected to grow from $27.35 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be rising healthcare investments, growing digital health adoption, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Nexuses Health, Avanade, Cerner, Wolter Kluwer, and McKesson.
Malaysia Connected Healthcare Market Analysis
The Malaysia-connected healthcare market is projected to grow from $106.69 Mn in 2022 to $798.09 Mn by 2030, registering a CAGR of 28.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare spending, the ageing population, high smartphone penetration and government support. The market is segmented by type, function and by application. Some of the major players include IHH Healthcare Berhad, Zuellig Pharma, Qualitas Medical Group, Siemens Healthineer, GE Healthcare and Medtronic.
Malaysia Neurology Clinical Trials Market Analysis
The Malaysia Neurology Clinical Trials market is projected to grow from $8.41 Mn in 2022 to $13.1 Mn by 2030, registering a CAGR of 5.7% during the forecast period of 2022 - 2030. The market will be driven by a well-developed healthcare infrastructure and a large pool of potential study participants. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Merck Sharp & Dohme Malaysia.
Malaysia Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Malaysia infectious disease therapeutics market will reach a value of $275.12 Mn from $192.72 Mn in 2022, growing at a CAGR of 4.6% during 2022-2030. Infectious Disease Therapeutics in Malaysia is dominated by a few domestic pharmaceutical companies such as Pharmaniaga Berhad, Duopharma Biotech and Kotra Pharma. The Infectious Disease Therapeutics market in Malaysia is segmented into different therapeutic areas and different diseases type. The major factors affecting the Malaysia infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of Malaysia.
Malaysia Artificial Intelligence (AI) in Diagnostics Market Analysis
Malaysia's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $1.6 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The market will be driven by the growing need in the healthcare industry for more precise and effective diagnostics, as well as the nation's expanding incidence of chronic illnesses. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & AIME Health.
Malaysia Neurology Devices Market Analysis
The Malaysia Neurology Devices Market is expected to witness growth from $20 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The expansion of the neurology devices market in Malaysia is being fueled by the development of cutting-edge neurology devices such as brain-computer interfaces and cutting-edge neuroimaging technologies. The market is segmented by treatment, route of administration, age group, and by distribution channel. Major Key players in Malaysia's neurology devices market include Medtronic, Abbott Laboratories, Nihon Kohden, Natus Medical, and B. Braun Melsungen.
Malaysia 3D Imaging Market Analysis
The Malaysia 3D Imaging market is projected to grow from $0.05 Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022 - 2030. The market will be driven by increasing healthcare expenditure, rising demand for advanced diagnostic tools, and growing awareness about the benefits of 3D Imaging. The market is segmented by product, application, by end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare
Malaysia HIV Therapeutics Market Analysis
By 2030, it is anticipated that the Malaysia HIV therapeutics market will reach a value of $xx Mn from $22.12 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as HVC Medical Supplies, KLSCAH, and Pharmaniaga Berhad. The market is driven by the prevalence of HIV infections and inequalities in the treatment of HIV. The HIV therapeutics market in Malaysia is segmented by type, product, and geography, end user, and distribution channel.
Malaysia Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Malaysia Dermatology drugs market will reach a value of $xx Mn from $27.33 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Kimia Farma, Pharmaniaga, and Scicom. The market is driven by the prevalence of dermatology conditions, awareness about dermatological health, and the availability of generic drugs. The dermatology drug market in Malaysia is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Malaysia Palliative Care Market Analysis
The Malaysia Palliative care market is projected to grow from $21.03 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be improving access to palliative services, the aging population, government support, and technological advancements. The market is segmented by service type and by the end user. Some of the major players include Genesis Life Care Center, Lifelink Homecare, Pantai Hospital, KPJ Health, and Econ Healthcare.
Malaysia Nutritional Supplements Market Analysis
By 2030, it is anticipated that the Malaysia Nutrition and Supplements market will reach a value of $xx Mn from $613 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Careddi, NutriAsia, and Nutrilite by Amway. The market for nutrition and supplements in Malaysia is primarily driven by e-commerce platforms and increasing consumer awareness of health and lifestyle. The Malaysia nutrition and supplements market in Malaysia is segmented by Type, Product, application, and Distribution Channel.